68071-4532 : Pentoxifylline 400 mg Oral Tablet, Extended Release


NDC: 68071-4532
Labeler: Nucare Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Pentoxifylline
Dosage Form: Oral Tablet, Extended Release
Application #: ANDA075028
Rev. Date: 


Appearance:


Markings: BVF;0117
Shapes:  Oval
Colors:  White
Size (mm): 16
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

BVF 0117: (0093-5116) Pentoxifylline 400 mg Oral Tablet, Extended Release by Nucare Pharmaceuticals, Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 68071-4532-9: 90 TABLET, EXTENDED RELEASE IN 1 BOTTLE (68071‑4532‑9)

Active Ingredients:

  • Pentoxifylline

Dosage Strength:

  • 400 mg

Inactive Ingredients:

  • Isopropyl Alcohol
  • Magnesium Stearate
  • Povidone, Unspecified
  • Talc /

Pharmaceutical Classes:

  • Blood Viscosity Reducer [EPC]
  • Hematologic Activity Alteration [PE]

Related Products:

Based on records with the same trade name.
  • 66267-710 Pentoxifylline 400 mg Oral Tablet, Extended Release by Nucare Pharmaceuticals, Inc.
  • 0093-5116 Pentoxifylline 400 mg Extended Release Tablet by Teva Pharmaceuticals USA Inc
  • 0378-0357 Pentoxifylline 400 mg Extended Release Tablet by Mylan Pharmaceuticals Inc.
  • 0615-4523 Pentoxifylline 400 mg Extended Release Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-8305 Pentoxifylline 400 mg Oral Tablet, Extended Release by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-8511 Pentoxifylline 400 mg Oral Tablet, Extended Release by Ncs Healthcare of Ky, LLC Dba Vangard Labs
  • 0904-5448 Pentoxifylline 400 mg Extended Release Tablet by Major Pharmaceuticals
  • 16571-856 Pentoxifylline 400 mg Oral Tablet, Extended Release by Rising Pharma Holdings, Inc.
  • 16590-856 Pentoxifylline 400 mg Extended Release Tablet by Stat Rx USA LLC
  • 33261-992 Pentoxifylline 400 mg/1 Oral Tablet, Extended Release by Aidarex Pharmaceuticals LLC
  • 42291-687 Pentoxifylline 400 mg Extended Release Tablet by Avkare, Inc.
  • 43063-188 Pentoxifylline 400 mg Extended Release Tablet by Pd-rx Pharmaceuticals, Inc.
  • 43353-123 Pentoxifylline 400 mg Oral Tablet, Extended Release by Aphena Pharma Solutions - Tennessee, LLC
  • 49999-542 Pentoxifylline 400 mg Oral Tablet, Extended Release by Lake Erie Medical Dba Quality Care Products LLC
  • 51079-889 Pentoxifylline 400 mg Extended Release Tablet by Udl Laboratories, Inc.
  • 52125-214 Pentoxifylline 400 mg Extended Release Tablet by Remedyrepack Inc.
  • 53808-0516 Pentoxifylline 400 mg Extended Release Tablet by State of Florida Doh Central Pharmacy
  • 53808-0757 Pentoxifylline 400 mg Extended Release Tablet by State of Florida Doh Central Pharmacy
  • 53808-0758 Pentoxifylline 400 mg Extended Release Tablet by State of Florida Doh Central Pharmacy
  • 54569-5972 Pentoxifylline 400 mg Oral Tablet, Extended Release by A-s Medication Solutions
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68071-4532 QR Code

< Prev: 68071-4531Next: 68071-4533 >

Related Discussions:

Pentoxifylline Drug Uses
I would like to know what this medication is used for? ## Pentoxifylline is used to treat intermittent claudication resu... 1 reply
Taking Pentoxifylline for Poor Foot Circulation
I have just started taking Pentoxifylline and am wondering if anyone has experienced bad side effects? I have very poor ... 1 reply
Where has PENTOXIFYLLINE gone?
Trying to learn why Pentoxifylline is no longer available. the pill is oval, light lavendar, has the word MYLAN and the ... 3 replies
Pentoxifylline and Anxiety
How can I counteract the anxiety side effect of Pentoxifylline? I'm aware that it is a D1 receptor agonist. Could a ... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.